Only two children in need of urgent spinal surgeries have received treatment abroad this year, even after a legal directive mandated the HSE to provide options for all children with scoliosis.
The potential dangers of adopting foreign price controls for life-saving medications include the risk of tying U.S. medicine prices to foreign government-set prices, which disrupts innovation.
The Trump administration's healthcare policy changes have sparked a great deal of concern about their short and long-term consequences, especially regarding medical research funding.
President Trump's executive order requires Most Favored Nation (MFN) pricing, setting U.S. drug prices to the lowest rates charged overseas, particularly in wealthier European countries.
The medics outlined the extensive changes that have been implemented since the pause, including the completion of all of the recommendations advised by the chief medical officer (CMO).